CYCLOPHARM LIMITED - Announcements

1.02%

99.0¢

Market Cap $110.0M

Technology Scientific & Technical Instruments

Cyclopharm Limited is an Australia-based radiopharmaceutical company. The Company's... Cyclopharm Limited is an Australia-based radiopharmaceutical company. The Company's principal activity is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector. Its segments include Technegas and Molecular Imaging. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease. The Company uses Technegas technology, which is a structured ultra-fine dispersion of radioactive labelled carbon, produced by using driedTechnetium-99m in a carbon crucible. The Company distributes its products in approximately 65 countries.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CYC	Entitlement Offer	PRICE SENSITIVE	05/06/17	1.43MB	Share
CYC	Response to ASX query on Appendix 3Y		02/06/17	610.12KB	Share
CYC	CYC - Positive Results of China Clinical Trial	PRICE SENSITIVE	01/06/17	64.64KB	Share
CYC	Change of Director's Interest Notice		31/05/17	759.1KB	Share
CYC	CYC May 2017 Investor Presentation		12/05/17	1.04MB	Share
CYC	Announcement of buy-back - Appendix 3C	PRICE SENSITIVE	09/05/17	120.24KB	Share
CYC	Results of Meeting		09/05/17	131KB	Share
CYC	Managing Director's Address to Shareholders	PRICE SENSITIVE	09/05/17	171.02KB	Share
CYC	Chairman's Address to Shareholders		09/05/17	113.79KB	Share
CYC	CYC 2017 AGM Presentation		09/05/17	1.43MB	Share
CYC	Final share buy-back notice - Appendix 3F		08/05/17	129.54KB	Share
CYC	Appendix 3B		19/04/17	698.14KB	Share
CYC	Notice of Annual General Meeting/Proxy Form		07/04/17	674.76KB	Share
CYC	Initial Director's Interest Notice		03/04/17	114.26KB	Share
CYC	CYC Board Changes		29/03/17	359.6KB	Share
CYC	CYC Appendix 4G		28/03/17	80.89KB	Share
CYC	CYC Annual Report to Shareholders		28/03/17	1.7MB	Share
CYC	Change in substantial holding from CVC		17/03/17	151.67KB	Share
CYC	Becoming a substantial holder - AACCF (Amended)		09/03/17	300.27KB	Share
CYC	CYC 2016 Financial Year Results Investor Presentation		06/03/17	1.2MB	Share
CYC	Ceasing to be a substantial holder - Lloyds (Amended)		01/03/17	1.43MB	Share
CYC	CYC-Record Revenues and Operating EBITDA, Final Div Declared		27/02/17	400.3KB	Share
CYC	Cyclopharm Amended 2016 Preliminary Financial Report	PRICE SENSITIVE	27/02/17	922.78KB	Share
CYC	Dividend/Distribution - CYC		22/02/17	24.01KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	22/02/17	1.03MB	Share
CYC	Becoming a substantial holder - AACCF		17/02/17	759.92KB	Share
CYC	Ceasing to be a substantial holder - Lloyds		17/02/17	1.13MB	Share
CYC	CYC 2016 PRELIMINARY HEADLINE UPDATE-RECORD RESULTS	PRICE SENSITIVE	06/02/17	108.03KB	Share
CYC	Release Date of 2016 Full Year Preliminary Financial Results		01/02/17	117.42KB	Share
CYC	Change of Director's Interest Notice		25/11/16	102.16KB	Share
CYC	CYC Achieves USFDA Agreement For Technegas Trial Design	PRICE SENSITIVE	23/11/16	125.4KB	Share
CYC	Change of Company Address-CYC.AX		31/10/16	123.22KB	Share
CYC	Becoming a substantial holder from AEF,AEF-CYC.AX		20/10/16	349.79KB	Share
CYC	Becoming a substantial holder from AEF,AEF-CYC.AX		20/10/16	349.79KB	Share
CYC	Cyclopharm CEO Microcap Investment Conference Presentation-CYC.AX		19/10/16	801.31KB	Share
CYC	Cyclopharm Business Update on Significant Milestones-CYC.AX	PRICE SENSITIVE	13/10/16	142.01KB	Share
CYC	Chairman to Stand Down Temporarily-CYC.AX		07/10/16	237.13KB	Share
CYC	CYC Share Registry Details-CYC.AX		29/08/16	233.12KB	Share
CYC	Cyclopharm Limited 1H2016 Results Investor Presentation-CYC.AX		24/08/16	719.41KB	Share
CYC	Dividend/Distribution - CYC-CYC.AX		19/08/16	23.95KB	Share
CYC	Appendix 4D and Half Year Accounts-CYC.AX	PRICE SENSITIVE	19/08/16	1.95MB	Share
CYC	CEO Presentation at BioShares BioTech Summit 2016-CYC.AX		29/07/16	337.33KB	Share
CYC	Appendix 3B LTIP-CYC.AX		26/07/16	698.29KB	Share
CYC	Cyclopharm Investor Presentation 21 July 2016-CYC.AX		21/07/16	721.41KB	Share
CYC	CYC Strengthens Mgt Depth and Expands Clinical Expertise-CYC.AX		14/07/16	390.1KB	Share
CYC	Change of Director's Interest Notice-CYC.AX		28/06/16	261.52KB	Share
CYC	Change of Director's Interest Notice-CYC.AX		28/06/16	245.19KB	Share
CYC	CYC Signs Agreement with the Canadian Association of Nuc Med-CYC.AX	PRICE SENSITIVE	27/06/16	546.06KB	Share
CYC	Trading Update & Record Technegas Order Received from China-CYC.AX	PRICE SENSITIVE	21/06/16	330.68KB	Share
CYC	Announcement of buy-back - Appendix 3C-CYC.AX	PRICE SENSITIVE	11/05/16	235.19KB	Share
CYC	Board Changes / Appendix 3Z-CYC.AX		11/05/16	491.3KB	Share
CYC	Results of Annual General Meeting-CYC.AX		11/05/16	229.7KB	Share
CYC	Managing Director's Report-CYC.AX		11/05/16	339.49KB	Share
CYC	Managing Director's AGM Presentation-CYC.AX		11/05/16	1.12MB	Share
CYC	Chairman's Address to Shareholders-CYC.AX		11/05/16	372.21KB	Share
CYC	Cyclopharm to Proceed Independently with FDA Trials-CYC.AX	PRICE SENSITIVE	10/05/16	151.49KB	Share
CYC	Appendix 4G-CYC.AX		18/04/16	218.78KB	Share
CYC	Notice of Annual General Meeting/Proxy Form-CYC.AX		08/04/16	406.65KB	Share
CYC	Cyclopharm Limited Investor Presentation		17/03/16	1.63MB	Share
CYC	Annual Report to shareholders		17/03/16	1.52MB	Share
CYC	Dividend/Distribution - CYC		24/02/16	23.96KB	Share
CYC	Strong Technegas Earnings Underpin Record Profit		24/02/16	88.24KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	24/02/16	1.12MB	Share
CYC	Technegas COPD Trial Update	PRICE SENSITIVE	29/01/16	289.27KB	Share
CYC	Cyclopharm receives insurance settlement	PRICE SENSITIVE	31/12/15	208.49KB	Share
CYC	Response to ASX query re Appendix 3Y		26/11/15	289.07KB	Share
CYC	Change of Director's Interest Notice		26/11/15	141.97KB	Share
CYC	Change of Director's Interest Notice		05/11/15	321.6KB	Share
CYC	Change of Director's Interest Notice		26/10/15	105.12KB	Share
CYC	Change in substantial holding from CVC		22/10/15	228KB	Share
CYC	Change of Director's Interest Notice		22/10/15	314.54KB	Share
CYC	Change of Director's Interest Notice		19/10/15	315.24KB	Share
CYC	Cyclopharm Pays Maiden Dividend		14/10/15	268.31KB	Share
CYC	Change of Director's Interest Notice		12/10/15	313.46KB	Share
CYC	Cyclopharm Launches World-First Nuclear Medicine Technology		12/10/15	271.84KB	Share
CYC	CYC Investor Presentation 7 October 2015		07/10/15	2.29MB	Share
CYC	Change of Director's Interest Notice		06/10/15	314.91KB	Share
CYC	Change of Director's Interest Notice		01/10/15	313.96KB	Share
CYC	Change of Director's Interest Notice		25/09/15	106.62KB	Share
CYC	Change of Director's Interest Notice		24/09/15	104.92KB	Share
CYC	Change of Director's Interest Notice		21/09/15	107.21KB	Share
CYC	Change in substantial holding from CVC		18/09/15	17.5KB	Share
CYC	Change of Director's Interest Notice		17/09/15	104.92KB	Share
CYC	Cyclopharm signs Term Sheet with Jubilant Draximage	PRICE SENSITIVE	14/09/15	147.71KB	Share
CYC	Dividend/Distribution - CYC		27/08/15	23.96KB	Share
CYC	Cyclopharm Unveils Inaugural Dividend		26/08/15	287.53KB	Share
CYC	Half Yearly Report and Accounts	PRICE SENSITIVE	26/08/15	868.83KB	Share
CYC	CYC Investor Presentation July 2015		27/07/15	1.03MB	Share
CYC	Change of Director's Interest Notice		14/07/15	211KB	Share
CYC	Appendix 3B		14/07/15	308.14KB	Share
CYC	Change of Share Registry Name		10/07/15	125.36KB	Share
CYC	Results of Meeting		26/05/15	231.36KB	Share
CYC	Managing Director's Report		26/05/15	334.48KB	Share
CYC	Managing Director's AGM Presentation		26/05/15	1.07MB	Share
CYC	Chairman's Address to Shareholders		26/05/15	361.36KB	Share
CYC	Notice of Annual General Meeting/Proxy Form		24/04/15	596.62KB	Share
CYC	Annual Report to shareholders		31/03/15	1.14MB	Share
CYC	Investor Presentation		12/03/15	777.12KB	Share
CYC	Cyclopharm Reports Record Profit		19/02/15	276.45KB	Share
CYC	Preliminary Final Report	PRICE SENSITIVE	19/02/15	760.57KB	Share

CYC Entitlement Offer
05/06/17	PRICE SENSITIVE	1.43MB	Share
CYC Response to ASX query on Appendix 3Y
02/06/17		610.12KB	Share
CYC CYC - Positive Results of China Clinical Trial
01/06/17	PRICE SENSITIVE	64.64KB	Share
CYC Change of Director's Interest Notice
31/05/17		759.1KB	Share
CYC CYC May 2017 Investor Presentation
12/05/17		1.04MB	Share
CYC Announcement of buy-back - Appendix 3C
09/05/17	PRICE SENSITIVE	120.24KB	Share
CYC Results of Meeting
09/05/17		131KB	Share
CYC Managing Director's Address to Shareholders
09/05/17	PRICE SENSITIVE	171.02KB	Share
CYC Chairman's Address to Shareholders
09/05/17		113.79KB	Share
CYC CYC 2017 AGM Presentation
09/05/17		1.43MB	Share
CYC Final share buy-back notice - Appendix 3F
08/05/17		129.54KB	Share
CYC Appendix 3B
19/04/17		698.14KB	Share
CYC Notice of Annual General Meeting/Proxy Form
07/04/17		674.76KB	Share
CYC Initial Director's Interest Notice
03/04/17		114.26KB	Share
CYC CYC Board Changes
29/03/17		359.6KB	Share
CYC CYC Appendix 4G
28/03/17		80.89KB	Share
CYC CYC Annual Report to Shareholders
28/03/17		1.7MB	Share
CYC Change in substantial holding from CVC
17/03/17		151.67KB	Share
CYC Becoming a substantial holder - AACCF (Amended)
09/03/17		300.27KB	Share
CYC CYC 2016 Financial Year Results Investor Presentation
06/03/17		1.2MB	Share
CYC Ceasing to be a substantial holder - Lloyds (Amended)
01/03/17		1.43MB	Share
CYC CYC-Record Revenues and Operating EBITDA, Final Div Declared
27/02/17		400.3KB	Share
CYC Cyclopharm Amended 2016 Preliminary Financial Report
27/02/17	PRICE SENSITIVE	922.78KB	Share
CYC Dividend/Distribution - CYC
22/02/17		24.01KB	Share
CYC Preliminary Final Report
22/02/17	PRICE SENSITIVE	1.03MB	Share
CYC Becoming a substantial holder - AACCF
17/02/17		759.92KB	Share
CYC Ceasing to be a substantial holder - Lloyds
17/02/17		1.13MB	Share
CYC CYC 2016 PRELIMINARY HEADLINE UPDATE-RECORD RESULTS
06/02/17	PRICE SENSITIVE	108.03KB	Share
CYC Release Date of 2016 Full Year Preliminary Financial Results
01/02/17		117.42KB	Share
CYC Change of Director's Interest Notice
25/11/16		102.16KB	Share
CYC CYC Achieves USFDA Agreement For Technegas Trial Design
23/11/16	PRICE SENSITIVE	125.4KB	Share
CYC Change of Company Address-CYC.AX
31/10/16		123.22KB	Share
CYC Becoming a substantial holder from AEF,AEF-CYC.AX
20/10/16		349.79KB	Share
CYC Becoming a substantial holder from AEF,AEF-CYC.AX
20/10/16		349.79KB	Share
CYC Cyclopharm CEO Microcap Investment Conference Presentation-CYC.AX
19/10/16		801.31KB	Share
CYC Cyclopharm Business Update on Significant Milestones-CYC.AX
13/10/16	PRICE SENSITIVE	142.01KB	Share
CYC Chairman to Stand Down Temporarily-CYC.AX
07/10/16		237.13KB	Share
CYC CYC Share Registry Details-CYC.AX
29/08/16		233.12KB	Share
CYC Cyclopharm Limited 1H2016 Results Investor Presentation-CYC.AX
24/08/16		719.41KB	Share
CYC Dividend/Distribution - CYC-CYC.AX
19/08/16		23.95KB	Share
CYC Appendix 4D and Half Year Accounts-CYC.AX
19/08/16	PRICE SENSITIVE	1.95MB	Share
CYC CEO Presentation at BioShares BioTech Summit 2016-CYC.AX
29/07/16		337.33KB	Share
CYC Appendix 3B LTIP-CYC.AX
26/07/16		698.29KB	Share
CYC Cyclopharm Investor Presentation 21 July 2016-CYC.AX
21/07/16		721.41KB	Share
CYC CYC Strengthens Mgt Depth and Expands Clinical Expertise-CYC.AX
14/07/16		390.1KB	Share
CYC Change of Director's Interest Notice-CYC.AX
28/06/16		261.52KB	Share
CYC Change of Director's Interest Notice-CYC.AX
28/06/16		245.19KB	Share
CYC CYC Signs Agreement with the Canadian Association of Nuc Med-CYC.AX
27/06/16	PRICE SENSITIVE	546.06KB	Share
CYC Trading Update & Record Technegas Order Received from China-CYC.AX
21/06/16	PRICE SENSITIVE	330.68KB	Share
CYC Announcement of buy-back - Appendix 3C-CYC.AX
11/05/16	PRICE SENSITIVE	235.19KB	Share
CYC Board Changes / Appendix 3Z-CYC.AX
11/05/16		491.3KB	Share
CYC Results of Annual General Meeting-CYC.AX
11/05/16		229.7KB	Share
CYC Managing Director's Report-CYC.AX
11/05/16		339.49KB	Share
CYC Managing Director's AGM Presentation-CYC.AX
11/05/16		1.12MB	Share
CYC Chairman's Address to Shareholders-CYC.AX
11/05/16		372.21KB	Share
CYC Cyclopharm to Proceed Independently with FDA Trials-CYC.AX
10/05/16	PRICE SENSITIVE	151.49KB	Share
CYC Appendix 4G-CYC.AX
18/04/16		218.78KB	Share
CYC Notice of Annual General Meeting/Proxy Form-CYC.AX
08/04/16		406.65KB	Share
CYC Cyclopharm Limited Investor Presentation
17/03/16		1.63MB	Share
CYC Annual Report to shareholders
17/03/16		1.52MB	Share
CYC Dividend/Distribution - CYC
24/02/16		23.96KB	Share
CYC Strong Technegas Earnings Underpin Record Profit
24/02/16		88.24KB	Share
CYC Preliminary Final Report
24/02/16	PRICE SENSITIVE	1.12MB	Share
CYC Technegas COPD Trial Update
29/01/16	PRICE SENSITIVE	289.27KB	Share
CYC Cyclopharm receives insurance settlement
31/12/15	PRICE SENSITIVE	208.49KB	Share
CYC Response to ASX query re Appendix 3Y
26/11/15		289.07KB	Share
CYC Change of Director's Interest Notice
26/11/15		141.97KB	Share
CYC Change of Director's Interest Notice
05/11/15		321.6KB	Share
CYC Change of Director's Interest Notice
26/10/15		105.12KB	Share
CYC Change in substantial holding from CVC
22/10/15		228KB	Share
CYC Change of Director's Interest Notice
22/10/15		314.54KB	Share
CYC Change of Director's Interest Notice
19/10/15		315.24KB	Share
CYC Cyclopharm Pays Maiden Dividend
14/10/15		268.31KB	Share
CYC Change of Director's Interest Notice
12/10/15		313.46KB	Share
CYC Cyclopharm Launches World-First Nuclear Medicine Technology
12/10/15		271.84KB	Share
CYC CYC Investor Presentation 7 October 2015
07/10/15		2.29MB	Share
CYC Change of Director's Interest Notice
06/10/15		314.91KB	Share
CYC Change of Director's Interest Notice
01/10/15		313.96KB	Share
CYC Change of Director's Interest Notice
25/09/15		106.62KB	Share
CYC Change of Director's Interest Notice
24/09/15		104.92KB	Share
CYC Change of Director's Interest Notice
21/09/15		107.21KB	Share
CYC Change in substantial holding from CVC
18/09/15		17.5KB	Share
CYC Change of Director's Interest Notice
17/09/15		104.92KB	Share
CYC Cyclopharm signs Term Sheet with Jubilant Draximage
14/09/15	PRICE SENSITIVE	147.71KB	Share
CYC Dividend/Distribution - CYC
27/08/15		23.96KB	Share
CYC Cyclopharm Unveils Inaugural Dividend
26/08/15		287.53KB	Share
CYC Half Yearly Report and Accounts
26/08/15	PRICE SENSITIVE	868.83KB	Share
CYC CYC Investor Presentation July 2015
27/07/15		1.03MB	Share
CYC Change of Director's Interest Notice
14/07/15		211KB	Share
CYC Appendix 3B
14/07/15		308.14KB	Share
CYC Change of Share Registry Name
10/07/15		125.36KB	Share
CYC Results of Meeting
26/05/15		231.36KB	Share
CYC Managing Director's Report
26/05/15		334.48KB	Share
CYC Managing Director's AGM Presentation
26/05/15		1.07MB	Share
CYC Chairman's Address to Shareholders
26/05/15		361.36KB	Share
CYC Notice of Annual General Meeting/Proxy Form
24/04/15		596.62KB	Share
CYC Annual Report to shareholders
31/03/15		1.14MB	Share
CYC Investor Presentation
12/03/15		777.12KB	Share
CYC Cyclopharm Reports Record Profit
19/02/15		276.45KB	Share
CYC Preliminary Final Report
19/02/15	PRICE SENSITIVE	760.57KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 99.0¢		Change 0.010(1.02%)		Mkt cap ! $110.0M

Open	High	Low	Value	Volume
97.0¢	$1.01	96.0¢	$59.93K	61.24K

Buyers (Bids)

No.	Vol.	Price($)
1	4536	99.0¢

Sellers (Offers)

Price($)	Vol.	No.
$1.01	1239	1

View Market Depth

No.	Vol.	Price($)
1	4536	0.990
2	6040	0.960
1	1500	0.950
1	3120	0.930
1	3000	0.915

Price($)	Vol.	No.
1.010	1239	1
1.025	7920	1
1.040	457	1
1.110	1000	1
1.115	4968	1

Last trade - 16.10pm 08/08/2025 (20 minute delay)

CYC (ASX) Chart

CYCLOPHARM LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available